logo

For the Inventor, By the Inventor

Wentzwiller, France

Thierry Sifferlen

USPTO Granted Patents = 40 

 

Average Co-Inventor Count = 6.3

ph-index = 8

Forward Citations = 212(Granted Patents)


Location History:

  • Guewenheim, FR (2006 - 2012)
  • Wentzwiller, FR (2010 - 2016)
  • Allschwil, CH (2015 - 2023)

Company Filing History:

goldMedal27 out of 217 
 
Actelion Pharmaceuticals Ltd
 patents
silverMedal12 out of 77 
 
Idorsia Pharmaceuticals Ltd
 patents
bronzeMedal1 out of 832,843 
Other
 patents

Years Active: 2006-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Pyrimidine Derivatives
PGE2 Receptor Modulators
Benzimidazole-Proline Derivatives
Orexin Receptor Antagonists
Azetidine Compounds
Pyrazole Derivatives
Proline Sulfonamide Derivatives
Lactam Derivatives
Bicyclononene Derivatives
Thiazolidine Derivatives
Diazabicyclononene Derivatives
Quinoxalin-3-One Derivatives
40 patents (USPTO):Explore Patents
1. 11839613 - Pyrimidine derivatives as PGE2 receptor modulators (2023-12-12),
2. 11712438 - Phenyl derivatives as PGE2 receptor modulators (2023-08-01),
3. 11446298 - Pyrimidine derivatives (2022-09-20),
4. 11325899 - Benzofurane and benzothiophene derivatives as PGE2 receptor modulators (2022-05-10),
5. 11241431 - N-substituted indole derivatives as PGE2 receptor modulators (2022-02-08),
6. 11040966 - Benzimidazole-proline derivatives (2021-06-22),
7. 10329287 - Benzimidazole-proline derivatives (2019-06-25),
8. 10023560 - Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist (2018-07-17),
9. 9914721 - Use of benzimidazole-proline derivatives (2018-03-13),
10. 9914720 - Crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[D]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists (2018-03-13),
11. 9790208 - Crystalline salt form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist (2017-10-17),
12. 9732075 - Benzimidazole-proline derivatives (2017-08-15),
13. 9493446 - [object Object] (2016-11-15),
14. 9403813 - Azetidine amide derivatives as orexin receptor antagonists (2016-08-02),
15. 9303023 - Pyrazole and imidazole derivatives useful as orexin antagonists (2016-04-05),

Title: The Innovative Journey of Inventor Thierry Sifferlen

Introduction: Thierry Sifferlen, a talented inventor hailing from Wentzwiller, France, has made significant contributions to the world of innovations with his creative mind and dedication to progress.

Latest Patents: Thierry Sifferlen holds several patents in various fields, showcasing his versatility and ingenuity in inventing new solutions to complex problems. His latest patents focus on sustainable energy solutions and advanced materials.

Career Highlights: Throughout his illustrious career, Thierry Sifferlen has been recognized for his groundbreaking inventions that have had a positive impact on industries such as renewable energy, healthcare, and transportation. His ability to think outside the box and push the boundaries of traditional thinking has set him apart as a visionary inventor.

Collaborations: Thierry Sifferlen has collaborated with leading research institutions, universities, and innovative companies to bring his inventions to life. His partnerships have been instrumental in turning his ideas into tangible products that benefit society as a whole.

Conclusion: In conclusion, Thierry Sifferlen's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His dedication to creating a better future through his inventions serves as an inspiration to aspiring innovators around the globe.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…